Characterization of an antibody that can detect the Kai1/CD82 murine metastasis suppressor

Mary C Custer1, John I Risinger, Shelley Hoover

  • 1Laboratory of Biosystems and Cancer, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA. custema@mail.nih.gov

The Prostate
|December 24, 2005
PubMed
Abstract

Insights

A new antibody specifically detects murine Kai1 (CD82), a metastasis suppressor. This tool aids research into Kai1

Area of Science:

  • Immunology
  • Molecular Biology
  • Cancer Research

Background:

  • Kai1 (CD82) is a tetraspanin protein involved in T-cell activation and cancer metastasis suppression.
  • Limited understanding of murine Kai1 function due to lack of specific antibodies.

Purpose of the Study:

  • To develop and characterize a novel polyclonal antibody for detecting murine Kai1.
  • To enable further investigation into Kai1's role in cancer metastasis.

Main Methods:

  • Generation of polyclonal antibody using peptide immunization in rabbits.
  • Validation via immunoblotting, flow cytometry, and immunohistochemistry.

Main Results:

  • The antibody specifically recognizes murine Kai1 and cross-reacts with rat Kai1, but not human KAI1.
  • Normal tissue distribution in mice mirrors that of the human homolog.
  • Differential expression of mouse prostatic epithelium observed within lobes.

Conclusions:

  • This is the first antibody capable of specifically detecting murine Kai1/CD82.
  • The antibody is a valuable tool for studying Kai1's mechanism in metastasis suppression.

Related Concept Videos